Rosenberg, S A <br/><br/>
Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2.  [electronic resource] 

 -  Journal of the National Cancer Institute  Aug 1994 
 - 1159-66 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0027-8874 
<br/><br/><label>Standard No.: </label>10.1093/jnci/86.15.1159  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Child<br/>Combined Modality Therapy--adverse effects<br/>Cyclophosphamide--therapeutic use<br/>Female<br/>Humans<br/>Injections, Intravenous<br/>Interleukin-2--adverse effects<br/>Lymphocytes, Tumor-Infiltrating--transplantation<br/>Male<br/>Melanoma--secondary<br/>Middle Aged<br/>Treatment Outcome<br/>Tumor Cells, Cultured